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Introduction
　Oxidative stress has been linked to retinopathy of prematurity （ROP） through several 
mechanisms related to the oxygenation of retinal tissue1, 2）.  ROP is one of the most impor-
tant causes of blindness and visual impairment in children3, 4）, and an effective treatment is 
required to prevent these vision problems 5）.  Oxygen-induced ischemic retinopathy （OIR） in 
the neonatal rat provides a good model system for studying the vascular changes that occur 
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Abstract : This study investigated the effect of N-［2-（2-oxo-1-imidazolidinyl） 
ethyl］-N-phenylurea （ethylene diurea, EDU） on oxygen-induced ischemic 
retinopathy （OIR） in a neonatal rat model.  OIR was induced by maintaining 
daily cycles of 80％ oxygen （20.5 h）, ambient air （0.5 h）, and a progressive 
return to 80％ oxygen （3 h） for 12 days （postnatal day : P12）.  The rats were 
treated intraperitoneally with EDU （30 mg / kg body weight） or distilled water 
（DW） from P6 to P17.  At P18, the percentage of avascular areas in the total 
retinal area （％AVA） was measured, and retinal neovascularization （NV） was 
scored in ADPase-stained retinas.  Retinal superoxide dismutase （SOD） activ-
ity in the retina was also determined by a chemiluminescence method.  The 
mean ％AVA in the EDU-treated group （9.3±1.7％, n＝ 16） was lower than 
in the DW group （18.2 ± 4.7％, n ＝ 17）.  EDU did not signicantly affect 
NV, but significantly increased SOD activity （1.36±0.13 units / mg protein, 
n ＝ 4） compared to DW treatment （1.04±0.01 units / mg protein, n ＝ 4, 
P＝ 0.032） at P18.  These results suggest that EDU treatment decreased the 
％AVA, accompanied by an increase in normal retinal vascular growth and / or 
a decrease in vessel proliferation.  The increased SOD activity observed in the 
present study is likely to involve the EDU-mediated effects.
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in ROP 6）.  This animal model has similarities to the oxygen stresses that preterm infants 
experience in modern-day neonatal intensive care units in that the affected rats develop 
an appearance similar to stage 3 ROP with intravitreous neovascularization （NV） at the 
junction of the vascular and avascular retina.  Using the OIR rat model, previous studies 
have shown that a high oxygen concentration inhibits vascular growth in the retina and 
subsequent normal oxygen concentration in the air promotes NV 6）.  During angiogenesis in 
the OIR retina, several angiogenic factors have been identied including vascular endothelial 
growth factor （VEGF）7-9）, VEGF receptor-1 （VEGFR-1）9）, insulin-like growth factor 1 
（IFG-1）9, 10）, and matrix metalloproteinases （MMPs）11）; these factors are promoted by reac-
tive oxygen species （ROS）.  Superoxide dismutase （SOD） is involved in the metabolism 
of ROS, catalyzing the dismutation of O2- to H2O2.  H2O2 is generally metabolized by 
peroxisomal catalase, while glutathione peroxidase metabolizes mitochondrial or cytosolic 
H2O2.  Therefore, increased SOD activity may inhibit NV in the OIR retina.  The experi-
mental chemical, ethylene diurea （EDU : N-［2-（2-oxo-1-imidazolidinyl）ethyl］-N-phenylurea） 
was reported to protect plants from otherwise damaging doses of the air pollutant, ozone 
（O3）12, 13）.  EDU promoted the activity of SOD and catalase in the leaves of a normally O3 - 
sensitive snap bean cultivar and protected against acute and chronic foliar injuries due to 
O314, 15）.  EDU has also induced SOD and catalase activity both in vitro （human gingival 
broblasts）16） and in vivo （rat heart, liver, and lung） without adverse effects17）.  This study 
investigated the effect of EDU on retinal NV in the OIR neonatal rat model. 
Materials and Methods
　All animals were cared for in accordance with the ARVO Statement for the Use of Ani-
mals in Ophthalmic and Vision Research.  The Institutional Committee of Animal Care and 
Use at our institution approved the study protocol.
Animal model
　Female Sprague-Dawley rats at 14 days gestation were purchased from CREA Japan Co., 
Ltd. （Tokyo, Japan）.  Rats were divided into two groups : room-air and oxygen-exposed. 
In both groups, 13 or 14 neonatal rats were kept with a mother in each cage after birth. 
Mother rats were rotated between the room-air and oxygen-exposed groups every two days 
during the experimental period.  Retinal NV was induced in neonatal rats by our standard 
protocol6）.  The oxygen-exposed rats were exposed from birth to day 12 （postnatal day : 
P12） to daily cycles of 80％ oxygen （20.5 h）, room air （0.5 h）, and then a progressive 
return to 80％ oxygen （3 h）.  On P12, the oxygen-exposed rats were placed in room air 
until the end of experiments at P18 （Fig. 1）.
Treatment schedule 
　The rats were treated by intraperitoneal （i.p.） injection of either 30 mg / kg EDU or 
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distilled water （DW） in a constant volume of 50μl / 10 g body weight once daily from P6 
to P17.  Body weight was measured every 2 days from P0 to P18.
Retinal processing and analysis
　At P18, the rats were sacriced by i.p. injection of 0.3 ml sodium pentobarbital （50 mg /
ml） and enucleated eyes were fixed in 4％ paraformaldehyde in cacodylate buffer （0.1 
M, pH7.2） for 48 hours, stained with ADPase, and at-mounted6）.  Digital images of the 
ADPase-stained retinas were obtained using a camera and scanner （Nikon, Tokyo, Japan）, 
with retinal NV scored using the method of Hasebe et al 18）.  The intensity of NV in 
each retina was scored as thickened vascular long ridge : 4, short ridge : 3, ve or more 
glomerular buds : 2, less than ve glomerular buds : 1, and none observed : 0.  Avascular 
areas （AVAs） were also measured in the ADPase-stained retinas, with the avascular and 
total retinal areas measured using NIH image software （NIH, Bethesda, MD）.  The mean 
percentages of AVAs per total retinal area （％AVAs） were calculated. 
Quantication of vascular endothelial growth factor （VEGF） protein and SOD activity
　Retinal samples were collected from the sacriced rats and immersed in 100μl of tissue 
protein-extraction reagent （T-PER, Thermo Fisher Scientic Inc, Rockford, IL） containing a 
protease inhibitor cocktail （Sigma-Aldrich, St. Louis, MO ; 1 : 100）, and then stored at 
-40℃ until analysis.  The samples were then cut into small pieces with scissors, sonicated 
in 5-s bursts at 40 W （Branson Sonier Cell Disruptor 200, Branson, Rochester Hills, MI）, 
and centrifuged at 3000 rpm for 10 min.  VEGF in the supernatant was assayed using a rat 
VEGF immunoassay kit （R&D Systems, Minneapolis, MN）.  SOD activity was determined 
by a chemiluminescence method 19）, based on the inhibition of integrated light intensity 
Fig. 1.  The treatment schedule
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generated by O2- production in biological systems.  The reaction mixture contained 25 mM 
2-methyl-6-（p-methoxyphenyl）-3,7-dihydroimidazo［1,2-a］pyrazin-3-one hydrochloride （MCLA : 
Fluka, Tokyo）, 25 mM hypoxanthine （Sigma-Aldrich）, and 3.38×10-6 units xanthine oxidase 
（Sigma-Aldrich） in 42.5 mM Tris buffer （Wako, Osaka）, pH 7.4.  Reactions were carried 
out at 25℃ and the chemiluminescence was measured using a Luminescence reader BLR-
301 （Aloka, Tokyo）. 
　Protein concentrations were determined using a BCA protein assay reagent kit （Thermo 
Fisher Scientic, Rockford, IL） using bovine serum albumin as the standard. 
Statistical Analysis
　Statistical analysis was performed using the Mann-Whitney U-Test.  Results were consid-
ered statistically signicant when the P value was less than 0.05.
Results
　The body weight of rats treated with EDU increased similar to the DW-treated controls 
in both the room-air exposed and OIR groups.  Normal retinal vascular development was 
observed in all animals in the room-air groups （NVs were not observed in the DW- and 
EDU-treated groups）.  OIR retinas exhibited neovascular changes and retained avascular 
areas （Fig. 2）.  In the DW- and EDU-treated groups, ％AVAs were 18.2±4.7％ （n＝ 17） 
and 9.3 ± 1.7％ （n ＝ 16）, respectively （Fig. 3）, while NV scores were 6.0±0.96 and 5.94±
0.82, respectively （Fig. 4）.  The EDU treatment therefore suppressed ％AVA, but did not 
inuence the NV extent in the OIR rat retina.
　The quantity of VEGF protein in the OIR retinas increased significantly from P12 to 
P13 : from 71.7 ± 15.0 pg / mg protein to 588.2±229.4 pg / mg protein in the DW group and 
Fig. 2.   Rat oxygen-induced ischemic retinopathy （OIR） model. The typical samples of 
atmounted ADPase stained retinas at P18. （A） DW group, NV score is 9, 
％AVA is 25.9. （B） 50 mg / kg EDU-treated group, NV score is 7, ％AVA is 11.7.
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from 59.9 ± 16.1 pg / mg protein to 493.7±92.9 pg / mg protein in the EDU-treated group, 
and at P18, it decreased to 136.7±52.3 pg / mg protein in DW group and 136.2±47.5 pg /
mg protein in the EDU-treated group （Fig. 5）.  In the room-air group, VEGF levels were 
lower than in OIR animals at each time point.  In the EDU-treated group, VEGF levels 
were 27.2 ± 6.3 pg / mg protein at P12, 28.0±2.9 pg / mg protein at P13, and 32.7±4.3 pg /
mg protein at P18, while in DW-treated rats the comparable values were 23.5±2.7, 24.2±
14.6 and 33.7 ± 3.5 pg / mg protein, respectively.  Thus, EDU had no effect on VEGF levels 
in either the OIR or room-air groups.
Fig. 3.   Effect of 50 mg / kg EDU-treatment on ％AVA in the OIR. The open column 
shows ％AVA in DW group （n＝ 17） and the closed column shows ％AVA 
in EDU treated group （n＝ 16）. The data represent mean±SE （＊ : P＜ 0.05）.
Fig. 4.   Effect of 50 mg / kg EDU-treatment on NV score in the OIR. The open col-
umn shows NV score in DW group （n＝ 17） and the closed column shows 
NV score in EDU treated group （n＝ 16）. The data represent mean±SE.
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　SOD activity was signicantly increased in the OIR group at P18 following EDU treat-
ment （1.36 ± 0.13 units / mg protein, n＝ 3） compared with those treated with DW （1.04±
0.01 units / mg protein, n ＝ 3）.  In the room-air group, the SOD activity was 2.09±0.26 
units / mg protein in the EDU-treated group and 1.79±0.51 units / mg protein in the DW 
group at P18 （Fig. 6）.
Discussion
　In the present study, both ％AVAs and NV scores were signicantly higher in the oxygen-
exposed rat retinas compared to those in room air.  These ndings conrmed that our OIR 
neonatal rat model is a suitable model for the present study 8, 20）. 
　Oxidative stress has been linked to ROP through several mechanisms related to oxygen-
ation of retinal tissue and O2- production1）.  The retina is susceptible to oxidative damage 
given its high metabolic rate and rapid rate of oxygen consumption 21）.  In addition, the 
premature infant has a reduced ability to scavenge ROS 22）, increasing its vulnerability to oxi-
dative stress, which could also increase apoptosis and damage retinal tissues23）.  The major 
source of O2- in cells results from NAD（P）H oxidase activity.  Saito et al 24） reported that 
the NAD（P）H oxidase inhibitor, apocyanin, reduced avascularity and apoptosis in the OIR 
Fig. 5.   Effect of EDU treatment on VEGF contents in retina. The content of 
VEGF signicantly increased at P13 in OIR retina （open column : DW 
group, closed column : EDU-treated group）. The spotted and the slant-
ing line column show the contents of VEGF in DW and EDU-treated 
group in the room-air group. The data represent mean±SE pg / mg 
protein （n＝ 3 for each point）. ＊ : P＜ 0.05 compared to the value at 
P12 in each group.
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rat retina through pathways triggered by ROS generation 24）.  The cause of the increased 
％AVA in this model remains unclear.  However, cleaved caspase-3 was observed at vessels 
in the OIR retina, which may activate apoptosis 22）, thereby inhibiting blood vessel growth, 
and increasing the ％AVA. 
　Exogenously administered SOD and catalase are protective in animal models of oxygen-
derived free radical tissue injury 25, 26）.  In this study, SOD activity in the OIR rat retinas 
was increased to 131％ by the EDU treatment and catalyzed O2- dismutation in the retina. 
These data suggested that the decreased ％AVA in EDU-treated animals was due to 
increased O2- catalysis.  On the other hand, increased SOD activity leads to increased H2O2 
generation, and thus might trigger angiogenesis27-29）.  However, NV was not observed with 
EDU treatment in the room air-exposed rats in this study.  Hence, the noted increase in 
SOD activity did not enhance VEGF synthesis.  We speculate therefore that the increased 
H2O2 was immediately metabolized by catalase and glutathione peroxidase in the retina in 
this study. 
　ROP progresses in two phases.  The first phase begins with delayed retinal vascular 
growth after birth in a relatively hyperoxic condition and partial regression of existing 
vessels, followed by a second phase of hypoxia-induced pathological vessel growth1）.  We 
speculate that the oxygen exposure period from P1 to P12 in our OIR neonatal rat model 
simulated the rst phase, and the subsequent normal oxygen concentration in the air period 
Fig. 6.   Effect of EDU treatment on SOD activity in OIR and the room-air con-
trol retina. The columns are expressed as same as Fig. 5. The abscissa 
shows SOD activity in the retina （unit / mg protein）. The data represent 
mean ± SE units / mg protein （n＝ 4 for each point, ＊ : P＜ 0.05）.
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from P12 to P18 simulated the second phase of ROP progression.  During the rst phase, 
retinal vascular growth after birth might be enhanced by EDU treatment, due to the cataly-
sis of O2- dismutation ; thus, the ％AVA in EDU-treated rats was lower than in the DW 
group.  At P13, the levels of VEGF signicantly increased in both the DW- and EDU-treat-
ment groups by the relatively hypoxic conditions, but VEGF expression was not inuenced 
by EDU treatment in the OIR rat retina.  This phenomenon might also have resulted in 
the unchanged NV scores between the treatment groups.  During the second phase, NV is 
stimulated by triggering VEGF signaling, inammatory pathways, and TNF-alpha or other 
cytokines30）, with subsequent vitreous migration.  Bleeding easily occurs in these immature 
blood vessels and wound-healing NV starts31）.
　VEGF-A was also recently shown to differentially regulate angioblast sprouting behavior 
by promoting the expression of Notch ligand delta-like 432, 33）, which regulates the formation 
of the appropriate tip-cell numbers to control vessel sprouting and branching in the mouse 
retina 32）.  Notch-inhibitory gamma-secretase inhibitors raise tip-cell numbers, leading to exces-
sive vascular sprouting and fusion without VEGF-A expression change32）.  Future studies 
should therefore focus on the cellular steps comprising the rst and the second phases of 
ROP in the OIR model to resolve a causative mechanism. 
　The mechanism by which EDU induces SOD and catalase activities is unclear.  EDU 
does not act as a scavenger of O2- in the hypoxanthine and xanthine oxidase generation 
system in this experiment.  It is interesting that EDU treatment has the potential to reduce 
the retinal avascular area and lead to increased retinal development in ROP.
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